BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33443083)

  • 1. Semaphorin 3E Promotes Susceptibility to
    Ikeogu NM; Edechi CA; Akaluka GN; Feiz-Barazandeh A; Zayats RR; Salako ES; Onwah SS; Onyilagha C; Jia P; Mou Z; Shan L; Murooka TT; Gounni AS; Uzonna JE
    J Immunol; 2021 Feb; 206(3):588-598. PubMed ID: 33443083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
    J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 3E Protects against Chlamydial Infection by Modulating Dendritic Cell Functions.
    Thomas R; Wang S; Shekhar S; Peng Y; Qiao S; Zhang C; Shan L; Movassagh H; Gounni AS; Yang J; Yang X
    J Immunol; 2021 Mar; 206(6):1251-1265. PubMed ID: 33504621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection.
    Colpitts SL; Dalton NM; Scott P
    J Immunol; 2009 May; 182(9):5702-11. PubMed ID: 19380817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.
    Anderson CF; Stumhofer JS; Hunter CA; Sacks D
    J Immunol; 2009 Oct; 183(7):4619-27. PubMed ID: 19748991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins.
    Zaph C; Scott P
    J Immunol; 2003 Nov; 171(9):4726-32. PubMed ID: 14568948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice.
    Li J; Liu D; Mou Z; Ihedioha OC; Blanchard A; Jia P; Myal Y; Uzonna JE
    Eur J Immunol; 2015 Apr; 45(4):1082-91. PubMed ID: 25594453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
    Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
    Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.
    Barbi J; Snider HM; Bhardwaj N; Lezama-Dávila CM; Durbin JE; Satoskar AR
    FASEB J; 2009 Nov; 23(11):3990-9. PubMed ID: 19641143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.
    Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A
    Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant Notch1 and Notch2 signaling is necessary for IFNγ secretion by T helper 1 cells during infection with Leishmania major.
    Auderset F; Schuster S; Coutaz M; Koch U; Desgranges F; Merck E; MacDonald HR; Radtke F; Tacchini-Cottier F
    PLoS Pathog; 2012; 8(3):e1002560. PubMed ID: 22396647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin-3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C
    Kermarrec L; Eissa N; Wang H; Kapoor K; Diarra A; Gounni AS; Bernstein CN; Ghia JE
    Br J Pharmacol; 2019 May; 176(9):1235-1250. PubMed ID: 30736100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.